<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Psychiatry: Physical Examination Topic Collection</title>
    <link>http://archpsyc.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 12 Dec 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:51:01 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archpsyc.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archpsyc.jamanetwork.com</webMaster>
    <item>
      <title>Dorsal Striatal Size, Shape, and Metabolic Rate in Never-Medicated and Previously Medicated Schizophrenics Performing a Verbal Learning Task</title>
      <link>http://archpsyc.jamanetwork.com/article.aspx?articleID=190978</link>
      <pubDate>Sun, 01 Mar 1998 00:00:00 GMT</pubDate>
      <author>Shihabuddin L, Buchsbaum MS, Hazlett EA, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Background&lt;/div&gt;Magnetic resonance imaging and positron emission tomography were used to study the size and metabolic rate of the caudate and the putamen in 18 patients with schizophrenia (n=16) or schizo-affective disorder (n=2) and 24 age- and sex-matched control subjects.&lt;div class="boxTitle"&gt;Methods&lt;/div&gt;The patients were either never medicated (n=7) or drug free (n=11) for a median of 3 weeks. During uptake of fludeoxyglucose F 18, all patients performed a serial verbal learning test. Positron emission tomographic and magnetic resonance imaging scans were coregistered, and the caudate and the putamen were traced on the magnetic resonance image.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;The striatum had a significantly lower relative metabolic rate in schizophrenics than in controls. Never-medicated patients had lower metabolic rates in the right putamen (ventral part of the dorsal striatum) than previously medicated patients. The caudate was significantly smaller in never-medicated patients than in controls and largest in previously medicated patients. Patients with higher relative metabolic rates in the putamen scored higher on the Abnormal Involuntary Movements Scale.&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;The findings are consistent with reports of striatal enlargement in previously medicated patients and size increases after neuroleptic treatment. Never-medicated patients, in contrast, had ventral striatal structures that were smaller and less active than those observed in controls and previously medicated patients.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">55</prism:volume>
      <prism:number xmlns:prism="prism">3</prism:number>
      <prism:startingPage xmlns:prism="prism">235</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">243</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archpsyc.55.3.235</prism:doi>
      <guid>http://archpsyc.jamanetwork.com/article.aspx?articleID=190978</guid>
    </item>
  </channel>
</rss>